Skip to content

Clinical Trial on Acupuncture Adjuvant Treatment in the Pain After the Surgery of Gastrointestinal Carcinoma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02871999
Enrollment
60
Registered
2016-08-18
Start date
2016-08-31
Completion date
2019-01-01
Last updated
2019-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Carcinoma, Pain

Keywords

Acupuncture Therapy, Pain degree after surgery

Brief summary

Clinical trial on acupuncture adjuvant treatment in the pain after the surgery of gastrointestinal carcinoma. Gastrointestinal cancer patients are diagnosed by pathology or cell biology. Patients are randomized into 2 groups: The control group receive normal treatment only, the experimental group receive acupuncture therapy besides normal treatment. Clinical evaluation is based on the observation of the pain degree and life quality improvement. Blood biochemistry tests mainly include Prostaglandin E2(PGE2),5-hydroxytryptamine(5-HT), histamine(HIS), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), adrenaline, nor-adrenaline, tumor necrosis factor (TNF)-α, cell flow cytometry on Th1, Th2, Th17, Treg cytokines as well as serum cortisol, estradiol (female), progesterone (female), testosterone (male) etc.

Interventions

DEVICEAcupuncture therapy
PROCEDURELaparoscopic Surgery

Sponsors

Xiaonan Cui
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. General anesthesia,Gastric and Colorectal Cancer surgery under Laparoscopic; 2. Pathology diagnosed; 3. Brain, heart, lung, liver, kidney are at good condition before surgery; 4. No mental disorder, no conscious obstacle, no limbs disability.

Exclusion criteria

1. Severely complication after surgery; 2. Contraindication of the acupuncture; 3. Patients with mental disease; 4. Patients taking part in other clinical trials, being treated with other biotherapy or immunotherapy and researchers consider not suitable for clinical subjects for other reasons will be excluded.

Design outcomes

Primary

MeasureTime frame
Pain degree change after surgery, Graded according to Numerical Rating Scale(NRS)day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery

Secondary

MeasureTime frame
Prostaglandin E2(PGE2) in bloodday 2,day 7 after surgery
Estradiol(Female) in bloodday 2, day 7 after surgery
Th1/Th2 in bloodday 2, day 7 after surgery
Assessing the quality of life(QOL) change in 4 grades and recording: appetite, mental state, sleep, fatigue, attitude towards treatment, daily life abilityday 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
Histamine(HIS) in bloodday 2,day 7 after surgery
Th17/Treg in bloodday 2, day 7 after surgery
Testosterone(Male) in bloodday 2,day 7 after surgery
5-Hydroxytryptamine(5-HT) in bloodday 2,day 7 after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026